Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon May 24, 2019 8:55am

114 Views

Post# 29770486

RE:RE:RE:RE:RE:RE:RE:RE:RE:Time is of the essence

HIV specialists follow the CD4 count. It would be highly unusual for a GP to order it. Internists will order and interpret them in hospitalized patients but will invariably consult the HIV specialist. Bfw

palinc2000 wrote: I thought patients felt different before and after going in treatment If you dont mind one more question on this subject!! What triggers the blood test to determine CD 4 cell count? Are these test necessarily prescribed by the patients GP or by the patient HIV specialist?
bfw wrote: No, I dont think that would be the way to go about it. The MDR patient would have a very depressed immune system but will not necessarily feel any difference when the CD4 count goes from 50 to 200. However, their immune system will be stronger and they will be less susceptible to opportunistic infections. When I prescribe a BP med to a patient for hypertension, they usually dont feel better if their systolic pressure drops from 150 mm Hg to 139 mm Hg. However, they ar being protected from cardiovascular injury over the longer term. Patients/physicians need to become more fixated on achieving absence of viremia just as they focus on blood pressures. Bfw
palinc2000 wrote: BFW,

Can you describe the symptons of a patient just before being put on Trogarzo?
Do the symptoms disappear within 7-10 days?
What if he were to receive the first double dose for free ...?